Rankings
▼
Calendar
KYMR Q2 2025 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
KYMR
Kymera Therapeutics, Inc.
$7B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
-55.3% YoY
Gross Profit
$9M
81.8% margin
Operating Income
-$85M
-736.8% margin
Net Income
-$77M
-667.6% margin
EPS (Diluted)
$-0.95
QoQ Revenue Growth
-48.1%
Cash Flow
Operating Cash Flow
-$60M
Free Cash Flow
-$61M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$160M
Stockholders' Equity
$971M
Cash & Equivalents
$336M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$26M
-55.3%
Gross Profit
$9M
$26M
-63.4%
Operating Income
-$85M
-$51M
-66.0%
Net Income
-$77M
-$42M
-82.1%
← FY 2025
All Quarters
Q3 2025 →